CNY 60.07
(1.28%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 3.36 Billion | 3.2 Billion | 1.76 Billion | 1.46 Billion | 1.36 Billion | 471.28 Million |
Net Income | 4.77 Billion | 4.32 Billion | 3.68 Billion | 2.18 Billion | 1.01 Billion | 1.2 Billion |
Depreciation & Amortization | 589.94 Million | 411.81 Million | 308.68 Million | 259.78 Million | 200.17 Million | 138.16 Million |
Deferred income taxes | -17.36 Million | 52.76 Million | -117.03 Million | -67.78 Million | -24.33 Million | -48.92 Thousand |
Stock-based compensation | 296.27 Million | 210.03 Million | 217.5 Million | 60.98 Million | 31.51 Million | 14.37 Million |
Change in working capital | -2.42 Billion | -1.57 Billion | -2.04 Billion | -1.11 Billion | 37.23 Million | -868.73 Million |
Other non-cash items | 178.05 Million | -226.38 Million | -278.85 Million | 151.15 Million | 106.46 Million | -6.86 Million |
Investing Cash Flow | -454.47 Million | -2.74 Billion | -2.38 Billion | -503.67 Million | -1.3 Billion | 151.17 Million |
Investments in PPE | -1.5 Billion | -1.66 Billion | -778.58 Million | -358.32 Million | -250.89 Million | -283.94 Million |
Acquisitions | -341.95 Million | -141.98 Million | -69.55 Million | 899.96 Thousand | -1.25 Billion | -1.02 Million |
Investment purchases | -2.67 Billion | -4.71 Billion | -4.88 Billion | -2.5 Billion | -3.09 Billion | -5.24 Billion |
Sales/Maturities of investments | 3.79 Billion | 4.19 Billion | 3.24 Billion | 2.91 Billion | 3.55 Billion | 3.65 Billion |
Other Investing Activities | 280.77 Million | -416.88 Million | 109.2 Million | -555.15 Million | -267.4 Million | 2.02 Billion |
Financing Cash Flow | -322.84 Million | 2.44 Billion | 1.29 Billion | -448.78 Million | 1.05 Billion | -103.33 Million |
Debt repayment | -742.56 Million | -2.01 Billion | -675.42 Million | -1.52 Billion | -1.01 Billion | -245.85 Million |
Dividends payments | -957.62 Million | -790.06 Million | -619.1 Million | -309.55 Million | -331.31 Million | -512.52 Million |
Common Stock Repurchased | -45.49 Million | -153.41 Million | 961.89 Thousand | -82.79 Million | -11.65 Million | -16.2 Million |
Common Stock Issuance | - | 677.94 Million | -961.89 Thousand | 82.79 Million | 11.65 Million | - |
Other Financing Activities | 1.55 Billion | 4.83 Billion | 2.64 Billion | 1.44 Billion | 2.46 Billion | 655.03 Million |
Accounts receivables | -5.69 Billion | -3.86 Billion | -3.01 Billion | -2 Billion | 14.03 Million | -824.96 Million |
Accounts payables | 4.17 Billion | 3.58 Billion | 2.92 Billion | 1.75 Billion | 231.52 Million | 187.87 Million |
Inventory | -885.51 Million | -1.34 Billion | -1.84 Billion | -802.54 Million | -183.98 Million | -231.6 Million |
Other working capital | 369.35 Million | 52.76 Million | -117.03 Million | -67.78 Million | -24.33 Million | -637.13 Million |
Cash at beginning of period | 5.96 Billion | 3.02 Billion | 2.36 Billion | 1.85 Billion | 756.46 Million | 235.76 Million |
Cash at end of period | 8.53 Billion | 5.96 Billion | 3.02 Billion | 2.36 Billion | 1.85 Billion | 756.46 Million |
Capital Expenditure | -1.5 Billion | -1.66 Billion | -778.58 Million | -358.32 Million | -250.89 Million | -283.94 Million |
Effect of forex changes on cash | -19.61 Million | 26.43 Million | -11.86 Million | -13.19 Million | -3.71 Million | 1.57 Million |
Net cash flow / Change in cash | 2.57 Billion | 2.93 Billion | 667.8 Million | 501.69 Million | 1.1 Billion | 520.7 Million |
Free Cash Flow | 1.86 Billion | 1.53 Billion | 987.43 Million | 1.1 Billion | 1.11 Billion | 187.34 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.23 Billion | 1.3 Billion | 811.13 Million | 4.77 Billion | 1.42 Billion | 1.24 Billion |
Depreciation & Amortization | - | 189.67 Million | 189.67 Million | 589.94 Million | 181.32 Million | -237.78 Million |
Deferred income taxes | - | - | - | -17.36 Million | - | -1.85 Billion |
Stock-based compensation | - | - | - | 296.27 Million | 296.27 Million | -167.42 Million |
Change in working capital | - | - | - | -2.42 Billion | -6.21 Billion | 2.25 Billion |
Other non-cash items | 794.93 Million | 685.7 Million | -782.56 Million | 178.05 Million | -1.42 Billion | -540.9 Million |
Investing Cash Flow | -4.23 Billion | -889.04 Million | -1.8 Billion | -454.47 Million | -210.58 Million | 431.93 Million |
Investments in PPE | -556.23 Million | -365.49 Million | -281.11 Million | -1.5 Billion | -427.93 Million | -401.35 Million |
Acquisitions | -14.47 Million | -232.08 Million | 674.09 Thousand | -341.95 Million | -168.36 Million | -341.81 Million |
Investment purchases | -3.32 Billion | -5.95 Billion | -671.72 Million | -2.67 Billion | -369.43 Million | -327.69 Million |
Sales/Maturities of investments | 3.3 Billion | 6.11 Billion | 233.23 Million | 3.79 Billion | 516.47 Million | 1.17 Billion |
Other Investing Activities | -3.64 Billion | -452.31 Million | -1.08 Billion | 280.77 Million | 68.11 Million | 325.13 Million |
Financing Cash Flow | -1 Billion | -1.62 Billion | 612.48 Million | -322.84 Million | 970.75 Million | 244.45 Million |
Debt repayment | -668.13 Million | -343.01 Million | -558.35 Million | -742.56 Million | -331.18 Million | -141.13 Million |
Dividends payments | -1.2 Billion | -1.2 Billion | -27.49 Million | -957.62 Million | -28.49 Million | -52.53 Million |
Common Stock Repurchased | 70.02 Million | -70.02 Million | - | -45.49 Million | -45.49 Million | 45.49 Million |
Common Stock Issuance | - | - | - | - | - | -139.12 Million |
Other Financing Activities | -298.52 Million | 24.91 Million | 81.62 Million | 1.55 Billion | 1.33 Billion | 531.74 Million |
Accounts receivables | - | - | - | -5.69 Billion | -5.69 Billion | 1.59 Billion |
Accounts payables | - | - | - | 4.17 Billion | - | 195.57 Million |
Inventory | - | - | - | -885.51 Million | -885.51 Million | 664.73 Million |
Other working capital | - | - | - | 369.35 Million | 369.35 Million | -195.57 Million |
Cash at beginning of period | 6.64 Billion | 8.56 Billion | 8.53 Billion | 5.96 Billion | 5.85 Billion | 4.49 Billion |
Cash at end of period | 3.43 Billion | 6.93 Billion | 7.35 Billion | 8.53 Billion | 8.53 Billion | 5.85 Billion |
Capital Expenditure | -556.23 Million | -365.49 Million | -281.11 Million | -1.5 Billion | -427.93 Million | -401.35 Million |
Effect of forex changes on cash | 1.38 Million | -5.45 Million | -11.07 Million | -19.61 Million | -683.34 Thousand | -11.3 Million |
Net cash flow / Change in cash | -3.2 Billion | -1.62 Billion | -1.17 Billion | 2.57 Billion | 2.68 Billion | 1.36 Billion |
Free Cash Flow | 1.47 Billion | 1.43 Billion | -252.54 Million | 1.86 Billion | 1.5 Billion | 298.99 Million |
300715
3027
BIOA-B
4237
DTR
BLFY